HK1244000B
(en )
2020-05-22
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
HK1225655A1
(en )
2017-09-15
Pharmaceutical compositions comprising azd9291
BR112016021682A2
(en )
2018-06-26
cenicriviroc for the treatment of fibrosis
DK3253382T3
(en )
2022-02-14
PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
BR112016026879A2
(en )
2017-08-15
LIQUID PHARMACEUTICAL COMPOSITION
MA50541A
(en )
2021-04-07
PHARMACEUTICAL FORMULATIONS
MA42303A
(en )
2018-05-09
PHARMACEUTICAL FORMULATIONS
ZA201601656B
(en )
2017-06-28
Inhalable pharmaceutical composition
DK3191085T3
(en )
2021-06-28
ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS
DK3313370T3
(en )
2021-03-29
Ophthalmological pharmaceutical composition
DK3129057T3
(en )
2023-10-02
GLYCOLIPIDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THERAPEUTIC USE
ZA201700843B
(en )
2018-04-25
Oral pharmaceutical composition of isotretinoin
DK3280447T3
(en )
2019-05-13
PHARMACEUTICAL FORMULATIONS
PT3122330T
(en )
2018-11-13
Pharmaceutical compositions comprising levocetirizine
DK3256138T3
(en )
2022-05-16
PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM
DK3288933T3
(en )
2021-11-22
OXINDOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
GB201700560D0
(en )
2017-03-01
Pharmaceutical composition comprising docetaxel
PT3200772T
(en )
2022-10-19
Pharmaceutical compositions comprising alpelisib
DK3089740T3
(en )
2020-08-03
PHARMACEUTICAL COMPOSITION
PL3164110T3
(en )
2020-03-31
Pharmaceutical compositions for the treatment of psoriasis
TH1601000722A
(en )
2017-02-09
New compounds and their pharmaceutical compositions for treatment cystic fibrosis
DK3558261T3
(en )
2022-06-20
PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE
DK3481370T3
(en )
2021-06-07
PHARMACEUTICAL COMPOSITION INCLUDING BENZYDAMINE
MA42111A
(en )
2018-03-28
TOPICAL PHARMACEUTICAL COMPOSITIONS
TH1501006784A
(en )
2017-12-21
Low dose pharmaceutical composition